Pharmacokinetic (PK) and Safety Study of Meropenem in Young Infants With Intra-abdominal Infections
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
Meropenem is an antibiotic that is commonly used to treat serious infections. Although it is
used in premature and young infants, the correct dose is not known. The purpose of this study
is to determine the correct dose and the safety of meropenem for the treatment of complicated
intra-abdominal infections in these young babies.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)